The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer

Background: Programmed death ligand 1 (PD-L1) expression has been shown to predict benefit from anti-PD-1 treatment in several cancers. However, its predictive value in colorectal cancer seems limited. This study was aimed to explore the clinical and biomarker association of programmed death ligand...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Wei, Xiao-Li, Wu, Qi-Nian, Chen, Dong-liang, Zeng, Zhao-Lei, Lu, Jia-Bin, Liu, Ze-Xian, Ju, Huai-Qiang, Ren, Chao, Pan, Zhi-Zhong, Wang, Feng-Hua, Xu, Rui-Hua
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277645/
https://ncbi.nlm.nih.gov/pubmed/30519336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27735
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires